Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fred Saad

Showing results (951-960 of 993) with videos related to

Pageof 100
Sort By:
The Journal of Clinical Endocrinology and Metabolism|January 24, 2024
The European Network for the Study of Adrenal Tumors Staging System (2015): A United States ValidationLetizia Maria Ippolita Jannello, Reha-Baris Incesu, Simone Morra, et al.
Clinical Genitourinary Cancer|June 26, 2023
Cancer-Specific Mortality Differences in Specimen-Confined Radical Prostatectomy Patients According to Lymph Node InvasionFrancesco Barletta, Stefano Tappero, Simone Morra, et al.
Clinical Genitourinary Cancer|June 21, 2023
Differences in Survival of Clear Cell Metastatic Renal Cell Carcinoma According to Partial vs. Radical Cytoreductive NephrectomyCristina Cano Garcia, Rocco S Flammia, Mattia Piccinelli, et al.
World Journal of Urology|May 4, 2025
Effect of chemotherapy on cancer specific mortality in female locally advanced urethral cancerQuynh Chi Le, Natali Rodriguez Peñaranda, Andrea Marmiroli, et al.
Journal of Robotic Surgery|May 7, 2025
Costs of robot-assisted vs. open approaches for 5 major cancersFrancesco Di Bello, Natali Rodriguez Peñaranda, Andrea Marmiroli, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 5, 2024
Survival of stage III non-seminoma testis cancer patients versus simulated controls, according to race/ethnicitySimone Morra, Cristina Cano Garcia, Mattia Luca Piccinelli, et al.
Clinical Genitourinary Cancer|May 17, 2024
Unmarried Status Effect on Stage at Presentation and Treatment Patterns in Non-Metastatic Upper Tract Urothelial Carcinoma PatientsSimone Morra, Lukas Scheipner, Andrea Baudo, et al.
The Lancet. Oncology|November 12, 2013
Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trialJohn C Araujo, Géralyn C Trudel, Fred Saad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 21, 2017
Randomized, Noncomparative, Phase II Trial of Early Switch From Docetaxel to Cabazitaxel or Vice Versa, With Integrated Biomarker Analysis, in Men With Chemotherapy-Naïve, Metastatic, Castration-Resistant Prostate CancerEmmanuel S Antonarakis, Scott T Tagawa, Giuseppe Galletti, et al.
Urologic Oncology|January 10, 2017
Quality indicators in the management of bladder cancer: A modified Delphi studySatya R Khare, Armen Aprikian, Peter Black, et al.
Pageof 100

Showing results (951-960 of 993) with videos related to

Sort By:
Pageof 100
The Journal of Clinical Endocrinology and Metabolism|January 24, 2024
The European Network for the Study of Adrenal Tumors Staging System (2015): A United States ValidationLetizia Maria Ippolita Jannello, Reha-Baris Incesu, Simone Morra, et al.
Clinical Genitourinary Cancer|June 26, 2023
Cancer-Specific Mortality Differences in Specimen-Confined Radical Prostatectomy Patients According to Lymph Node InvasionFrancesco Barletta, Stefano Tappero, Simone Morra, et al.
Clinical Genitourinary Cancer|June 21, 2023
Differences in Survival of Clear Cell Metastatic Renal Cell Carcinoma According to Partial vs. Radical Cytoreductive NephrectomyCristina Cano Garcia, Rocco S Flammia, Mattia Piccinelli, et al.
World Journal of Urology|May 4, 2025
Effect of chemotherapy on cancer specific mortality in female locally advanced urethral cancerQuynh Chi Le, Natali Rodriguez Peñaranda, Andrea Marmiroli, et al.
Journal of Robotic Surgery|May 7, 2025
Costs of robot-assisted vs. open approaches for 5 major cancersFrancesco Di Bello, Natali Rodriguez Peñaranda, Andrea Marmiroli, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 5, 2024
Survival of stage III non-seminoma testis cancer patients versus simulated controls, according to race/ethnicitySimone Morra, Cristina Cano Garcia, Mattia Luca Piccinelli, et al.
Clinical Genitourinary Cancer|May 17, 2024
Unmarried Status Effect on Stage at Presentation and Treatment Patterns in Non-Metastatic Upper Tract Urothelial Carcinoma PatientsSimone Morra, Lukas Scheipner, Andrea Baudo, et al.
The Lancet. Oncology|November 12, 2013
Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trialJohn C Araujo, Géralyn C Trudel, Fred Saad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 21, 2017
Randomized, Noncomparative, Phase II Trial of Early Switch From Docetaxel to Cabazitaxel or Vice Versa, With Integrated Biomarker Analysis, in Men With Chemotherapy-Naïve, Metastatic, Castration-Resistant Prostate CancerEmmanuel S Antonarakis, Scott T Tagawa, Giuseppe Galletti, et al.
Urologic Oncology|January 10, 2017
Quality indicators in the management of bladder cancer: A modified Delphi studySatya R Khare, Armen Aprikian, Peter Black, et al.
Pageof 100